52 related articles for article (PubMed ID: 23323630)
1. An integrative cross-design synthesis approach to estimate the cost of illness: an applied case to the cost of depression in Catalonia.
Bendeck M; Serrano-Blanco A; García-Alonso C; Bonet P; Jordà E; Sabes-Figuera R; Salvador-Carulla L;
J Ment Health; 2013 Apr; 22(2):135-54. PubMed ID: 23323630
[TBL] [Abstract][Full Text] [Related]
2. Costs of depression in Catalonia (Spain).
Salvador-Carulla L; Bendeck M; Fernández A; Alberti C; Sabes-Figuera R; Molina C; Knapp M
J Affect Disord; 2011 Jul; 132(1-2):130-8. PubMed ID: 21402411
[TBL] [Abstract][Full Text] [Related]
3. Cost of depression in Europe.
Sobocki P; Jönsson B; Angst J; Rehnberg C
J Ment Health Policy Econ; 2006 Jun; 9(2):87-98. PubMed ID: 17007486
[TBL] [Abstract][Full Text] [Related]
4. The costs and benefits of enhanced depression care to employers.
Wang PS; Patrick A; Avorn J; Azocar F; Ludman E; McCulloch J; Simon G; Kessler R
Arch Gen Psychiatry; 2006 Dec; 63(12):1345-53. PubMed ID: 17146009
[TBL] [Abstract][Full Text] [Related]
5. Cost of borderline personality disorder in Catalonia (Spain).
Salvador-Carulla L; Bendeck M; Ferrer M; Andión O; Aragonès E; Casas M;
Eur Psychiatry; 2014 Oct; 29(8):490-7. PubMed ID: 25174269
[TBL] [Abstract][Full Text] [Related]
6. An analysis of the costs of treating schizophrenia in Spain: a hierarchical Bayesian approach.
Vázquez-Polo FJ; Negrín M; Cabasés JM; Sánchez E; Haro JM; Salvador-Carulla L
J Ment Health Policy Econ; 2005 Sep; 8(3):153-65. PubMed ID: 16278503
[TBL] [Abstract][Full Text] [Related]
7. Cost comparisons and methodological heterogeneity in cost-of-illness studies: the example of colorectal cancer.
Ó Céilleachair AJ; Hanly P; Skally M; O'Neill C; Fitzpatrick P; Kapur K; Staines A; Sharp L
Med Care; 2013 Apr; 51(4):339-50. PubMed ID: 23358383
[TBL] [Abstract][Full Text] [Related]
8. The economic burden of depression in 1990.
Greenberg PE; Stiglin LE; Finkelstein SN; Berndt ER
J Clin Psychiatry; 1993 Nov; 54(11):405-18. PubMed ID: 8270583
[TBL] [Abstract][Full Text] [Related]
9. Economic burden of schizophrenia: empirical analyses from a survey in Thailand.
Phanthunane P; Whiteford H; Vos T; Bertram M
J Ment Health Policy Econ; 2012 Mar; 15(1):25-32. PubMed ID: 22611090
[TBL] [Abstract][Full Text] [Related]
10. Cost-of-illness analysis. What room in health economics?
Tarricone R
Health Policy; 2006 Jun; 77(1):51-63. PubMed ID: 16139925
[TBL] [Abstract][Full Text] [Related]
11. The costs of treating depression.
Santiago JM
J Clin Psychiatry; 1993 Nov; 54(11):425-6. PubMed ID: 8270585
[No Abstract] [Full Text] [Related]
12. Are psychological treatments for depression in primary care cost-effective?
Bosmans JE; van Schaik DJ; de Bruijne MC; van Hout HP; van Marwijk HW; van Tulder MW; Stalman WA
J Ment Health Policy Econ; 2008 Mar; 11(1):3-15. PubMed ID: 18424872
[TBL] [Abstract][Full Text] [Related]
13. Does co-morbid depression impact diabetes related costs? Evidence from a cross-sectional survey in a low-income country.
Chereches RM; Litan CM; Zlati AM; Bloom JR
J Ment Health Policy Econ; 2012 Sep; 15(3):127-38. PubMed ID: 23001281
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness analysis of a rural telemedicine collaborative care intervention for depression.
Pyne JM; Fortney JC; Tripathi SP; Maciejewski ML; Edlund MJ; Williams DK
Arch Gen Psychiatry; 2010 Aug; 67(8):812-21. PubMed ID: 20679589
[TBL] [Abstract][Full Text] [Related]
15. [Depression--socioeconomic perspectives].
Sanne B; Dahl AA; Tell GS
Tidsskr Nor Laegeforen; 2001 Feb; 121(5):590-5. PubMed ID: 11301616
[TBL] [Abstract][Full Text] [Related]
16. The economic burden of affective disorders.
Rice DP; Miller LS
Br J Psychiatry Suppl; 1995 Apr; (27):34-42. PubMed ID: 7794592
[TBL] [Abstract][Full Text] [Related]
17. Cost effectiveness of the determination of autoantibodies against cyclic citrullinated peptide in the early diagnosis of rheumatoid arthritis.
Konnopka A; Conrad K; Baerwald C; König HH
Ann Rheum Dis; 2008 Oct; 67(10):1399-405. PubMed ID: 18192304
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of usual general practitioner care with or without antidepressant medication for patients with minor or mild-major depression.
Bosmans JE; Hermens ML; de Bruijne MC; van Hout HP; Terluin B; Bouter LM; Stalman WA; van Tulder MW
J Affect Disord; 2008 Nov; 111(1):106-12. PubMed ID: 18342952
[TBL] [Abstract][Full Text] [Related]
19. Modeling the value for money of changing clinical practice change: a stochastic application in diabetes care.
Hoomans T; Abrams KR; Ament AJ; Evers SM; Severens JL
Med Care; 2009 Oct; 47(10):1053-61. PubMed ID: 19648827
[TBL] [Abstract][Full Text] [Related]
20. The economic consequences of not treating depression.
Rupp A
Br J Psychiatry Suppl; 1995 Apr; (27):29-33. PubMed ID: 7794591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
